槐果碱对大鼠血浆中Umbralisib药代动力学的影响:新型UPLC-MS/MS方法
本研究建立了一种快速稳定的UPLC-MS/MS方法,用于定量分析大鼠血浆中Umbralisib,并评估槐果碱对其药代动力学的影响。结果显示,槐果碱联合给药后,Umbralisib的AUC0→∞和Cmax显著降低,CLz/F增加两倍以上,提示两者间可能存在草药-药物相互作用。
要点
- 槐果碱可显著降低Umbralisib在大鼠体内的暴露量。
- 联合用药时需关注潜在草药-药物相互作用。
- 所建UPLC-MS/MS方法线性范围0.5-1000 ng/ml,适用血浆检测。
核心结论
- 槐果碱显著改变Umbralisib在大鼠体内的药代动力学,提示存在草药-药物相互作用。
研究设计与样本
- 研究采用大鼠血浆样本,建立UPLC-MS/MS方法定量Umbralisib,并比较单用与联用槐果碱后的药代动力学参数。
主要发现
- 联用槐果碱后,Umbralisib的AUC0→∞从5416.665 ± 1,451.846 ng/ml•h降至2462.799 ± 535.736 ng/ml•h。
- 联用槐果碱后,Umbralisib的Cmax也显著降低。
- 联用槐果碱后,Umbralisib的CLz/F增加两倍以上。
关键数值与推荐
- UPLC-MS/MS方法线性范围为0.5–1,000 ng/ml。
- 精密度(RSD%)和准确度(RE%)均小于15%。
- Umbralisib平均回收率为86.3–96.2%,基质效应为97.8–112.0%。
临床怎么用
- 中医/中西医结合医生应关注含槐果碱中药与Umbralisib的潜在相互作用。
- 联合用药时需监测Umbralisib疗效,必要时调整剂量。
局限性
- 研究仅在大鼠中进行,结果需进一步临床验证。
- 未报告槐果碱的具体剂量及给药方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Umbralisib is a dual inhibitor of phosphatidylinositol 3-kinase delta (PI3Kδ) and casein kinase 1 epsilon (CK1ε) for treating marginal zone lymphoma (MZL) and follicular lymphoma (FL). This study aimed to develop a fast and stable ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for quantitative analysis of umbralisib in rat plasma and its application for evaluating the effect of sophocarpine on the pharmacokinetics of umbralisib. A direct protein preparation with acetonitrile was used to deal with rat plasma. Umbralisib and duvelisib (internal standard, IS) were isolated on a Waters Acquity UPLC BEH C18 column with mobile phase consisted of acetonitrile and 0.1% formic acid in water. The linear range was from 0.5 to 1,000 ng/ml. Both of the precision (RSD%) and accuracy (RE%) were less than 15% in a permissible range. The mean recovery and matrix effect of umbralisib were 86.3-96.2% and 97.8-112.0%, respectively. When umbralisib was combined with sophocarpine, AUC0→∞ of umbralisib was significantly reduced to 2462.799 ± 535.736 ng/ml•h from 5416.665 ± 1,451.846 ng/ml•h, and Cmax also was markedly diminished. Moreover, CLz/F was increased more than two times. This developed, optimized and technical UPLC-MS/MS method was extremely suitable for detecting the concentrations of umbralisib in rat plasma after an oral administration, and sophocarpine significantly changed the pharmacokinetics of umbralisib in rats. This obvious pharmacokinetic changes indicates that there seems to exist herb-drug interaction between sophocarpine and umbralisib.
引用
- Weng Q, Lan X, Wang Y, et al. Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method. Front Pharmacol. 2022. PMID: 35126158. doi:10.3389/fphar.2022.749095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。